去年，武田制药表现最佳的业务板块Pharmaceutical Business实现营收4.42T美元。United States的营收贡献最高，去年达到2.16T美元。最近一个季度，截至2026-06-30，武田制药表现最佳的业务板块Gastrointestinal diseases实现营收386.10B美元。United States的营收贡献最高，达到568.90B美元。

业务

营业收入

占比

年报

年报

单季报

Pharmaceutical Business

Intellectual Property And Service Revenue

FY2026

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

Pharmaceutical Business

4.42T(98.17%)

4.50T(98.13%)

4.16T(97.65%)

3.92T(97.39%)

3.30T(92.34%)

3.11T(97.11%)

3.20T(97.36%)

2.03T(96.62%)

1.69T(95.67%)

Intellectual Property And Service Revenue

82.61B(1.83%)

85.58B(1.87%)

100.11B(2.35%)

105.20B(2.61%)

273.28B(7.66%)

92.44B(2.89%)

87.04B(2.64%)

70.95B(3.38%)

76.69B(4.33%)

地区

营业收入

占比

年报

年报

单季报

United States

Europe And Canada (Country)

Japan

Latin America

China (Country)

Others

Asia

Russia/CIS

United States

Europe

FY2026

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

United States

2.16T(48.05%)

--(--)

598.34B(33.79%)

520.16B(30.03%)

514.42B(28.46%)

426.13B(23.97%)

374.53B(22.14%)

Europe And Canada (Country)

1.15T(25.44%)

1.06T(23.03%)

966.84B(22.68%)

842.67B(20.92%)

739.17B(20.71%)

666.18B(20.83%)

645.53B(19.61%)

405.64B(19.34%)

313.72B(17.72%)

279.69B(16.15%)

309.27B(17.11%)

325.29B(18.30%)

--(--)

Japan

433.11B(9.61%)

418.46B(9.13%)

451.39B(10.59%)

512.04B(12.71%)

658.98B(18.46%)

559.75B(17.50%)

592.79B(18.01%)

571.02B(27.23%)

580.35B(32.78%)

655.34B(37.84%)

688.09B(38.07%)

712.81B(40.09%)

733.88B(43.38%)

Latin America

254.13B(5.64%)

235.85B(5.15%)

198.10B(4.65%)

160.38B(3.98%)

128.47B(3.60%)

121.64B(3.80%)

143.46B(4.36%)

88.11B(4.20%)

75.66B(4.27%)

72.52B(4.19%)

68.39B(3.78%)

85.37B(4.80%)

81.25B(4.80%)

China (Country)

195.14B(4.33%)

191.74B(4.19%)

--(--)

Others

133.89B(2.97%)

128.85B(2.81%)

117.91B(2.77%)

95.18B(2.36%)

68.94B(1.93%)

68.52B(2.14%)

71.26B(2.17%)

38.31B(1.83%)

30.19B(1.71%)

33.99B(1.96%)

39.42B(2.18%)

35.49B(2.00%)

29.54B(1.75%)

Asia

98.67B(2.19%)

99.39B(2.17%)

261.22B(6.13%)

225.01B(5.59%)

196.96B(5.52%)

156.24B(4.89%)

165.40B(5.03%)

105.41B(5.03%)

104.03B(5.88%)

112.80B(6.51%)

125.96B(6.97%)

111.41B(6.27%)

85.37B(5.05%)

Russia/CIS

79.72B(1.77%)

72.36B(1.58%)

72.59B(1.70%)

88.43B(2.20%)

62.06B(1.74%)

57.56B(1.80%)

76.83B(2.33%)

59.74B(2.85%)

68.24B(3.85%)

57.55B(3.32%)

61.82B(3.42%)

81.32B(4.57%)

89.57B(5.29%)

United States

--(--)

2.38T(51.94%)

2.20T(51.50%)

2.10T(52.24%)

1.71T(48.04%)

1.57T(49.03%)

1.60T(48.49%)

828.99B(39.53%)

--(--)

Europe

--(--)

297.55B(17.59%)